Engineered IFNγ-loaded exosomes reprogram macrophage polarization and suppress tumor cell proliferation in vitro
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115170 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yun Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, College of Biophotonics, School of Optoelectronic Science and Engineering…. Hauptthemen laut MEDLINE: Exosomes, Interferon-gamma, Macrophages, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, Guangzhou Science and Technology Program Key Projects.
Abstract (Originalsprache)
Macrophages are part of the immune system and play a complex role in the development of cancer. Tumor-associated macrophages (TAMs) exhibit dynamic plasticity between pro-tumorigenic (M2) and anti-tumorigenic (M1) phenotypes, presenting a promising therapeutic target for cancer immunotherapy. While pharmacological modulation of M2 to M1 repolarization shows therapeutic potential, current cytokine delivery strategies face critical challenges including non-specific macrophage clearance. To address these limitations, we developed an engineered exosome system (EXO-IFNγ) through efficient loading of interferon-γ (IFNγ) into THP-1 macrophage-derived exosomes. Functional investigations demonstrated that EXO-IFNγ effectively reprogrammed human peripheral blood mononuclear cells (PBMCs) derived M2 macrophages toward the M1 phenotype, exhibiting significantly superior polarization-modulating capacity compared to free IFNγ. To elucidate the therapeutic implications of phenotypic conversion, the bioactivity of conditioned medium (CM) derived from repolarized M1 macrophages was evaluated. The conditioned medium from repolarized M1 macrophages demonstrated potent tumor-suppressive activity, effectively inhibiting tumor cell growth and migration. Notably, the engineered exosomal delivery system demonstrated unique sustained payload release properties, endowing EXO-IFNγ generated CM with prolonged bioactivity compared to the CM produced by using IFNγ alone. Thus, EXO-IFNγ is a new macrophage polarization strategy to achieve good tumor cell killing effect by combining chemotherapy and immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, College of Biophotonics, School of Optoelectronic Science and Engineering, South China Normal University, Guangzhou 510631, China; Guangzhou Ke…
- Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China. Electronic address: zengchch@glmc.edu.cn.
Förderung
- Guangzhou Municipal Science and Technology Project
- Guangzhou Science and Technology Program Key Projects
Zitieren
APA
Chen, Y., Du, Z., Jiang, W., Kong, L., Huang, D., Zeng, C., & Liu, H. (2025). Engineered IFNγ-loaded exosomes reprogram macrophage polarization and suppress tumor cell proliferation in vitro. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115170
Vancouver
Chen Y, Du Z, Jiang W, Kong L, Huang D, Zeng C, et al. Engineered IFNγ-loaded exosomes reprogram macrophage polarization and suppress tumor cell proliferation in vitro. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115170
BibTeX
@article{Chen2025,
author = {Chen, Yun and Du, Zhuoling and Jiang, Weiwei and Kong, Linghong and Huang, Dan and Zeng, Changchun and Liu, Hanping},
title = {Engineered IFNγ-loaded exosomes reprogram macrophage polarization and suppress tumor cell proliferation in vitro},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115170}
}
EUVIMED